Camsing Healthcare (BAC) investor relations material

Executive summary

• H1 FY2027 revenue fell 18% YoY to S$1.702m; loss before tax widened to S$537k from S$423k, despite lower operating costs.

• Q2 revenue was broadly flat at S$831k, while loss before tax narrowed to S$238k from S$408k on lower marketing, administrative and finance costs.

• Continued operations depend on shareholder support, cost controls and revenue growth; material uncertainty remains over going-concern status.

Financial highlights

• H1 revenue S$1.702m, down 18% YoY; gross profit S$942k, down 15%; gross profit margin was not stated.

• H1 other income fell to S$29k from S$330k, with prior-year income including non-recurring interest waiver and lease termination gain.

• Marketing and distribution costs declined 22% to S$796k; administrative and other operating expenses declined 14% to S$682k.

• H1 net loss was S$537k versus S$423k; Q2 net loss improved to S$238k from S$408k.

Outlook and guidance

• Focus remains on disciplined cost management, operational efficiency and modest, sustainable growth; cautious optimism for improvement in coming periods is subject to unforeseen circumstances.

• Discussions with potential strategic partners continue to explore new revenue streams using the existing business.

• Cost-saving measures are expected to continue in FY2027; e-commerce revenue growth is expected to be maintained.